Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3779071017 | Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3779072012 | Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Is a | Bisoprolol and hydrochlorothiazide only product in oral dose form | true | Inferred relationship | Some | ||
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has BoSS | Bisoprolol fumarate | true | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has precise active ingredient | Bisoprolol fumarate | true | Inferred relationship | Some | 1 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has presentation strength numerator value | 6.25 | false | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Has BoSS | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets